CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
批准号:
3145433
负责人:
RANDALL J. COHRS
金额:
$13.96万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-01 至 1993-03-31
关键词:
DNA RNA RNA splicing antisense nucleic acid double stranded RNA electrophoresis enzyme complex glucocorticoids interferons microinjections molecular cloning natural gene amplification nucleic acid hybridization nucleic acid metabolism pancreatic ribonuclease plasmids temperature sensitive mutant tissue /cell culture transfection vaccinia virus virus genetics virus replication
中文摘要
RNA周转是基因表达调控的核心;然而,
其中涉及的机制还不是很清楚。温度敏感度
痘苗病毒突变体TS22为阐明
参与RNA周转的机制(S)。TS22基因调节
痘苗病毒感染细胞中RNA的稳定性。TS22病毒有一种
败育的晚期表型。在不允许的温度下,TS22感染
通常在早期阶段进行;然而,在感染后8-10小时,
RNA降解,病毒感染中止(独立于外源
干扰素治疗)。我们的结果表明,RNA的降解是
由于依赖2-5A的核糖核酸酶的激活。2-5A合成酶核糖核酸酶
途径,最初被发现是作为抗病毒机制之一
干扰素被认为与控制细胞内RNA的周转有关
生长、激素状态和分化。能够调节2-
5A通路在评价其在RNA降解中的作用方面具有一定的价值。我们
假设功能性TS22基因产物使2-5A失活
系统在产生性感染期间。2-5A通路的失活
不依赖病毒的功能性TS22基因产物的表达
感染,应有助于阐明2-5A通路在细胞RNA中的作用
营业额。我们建议研究TS22基因对2-5A通路的调控
产品。这将通过确定TS22的增长来实现
痘苗病毒和rRNA裂解(2-5A激活的指标
系统)在不允许的温度下,在其中2-5A
路径已无法运行。的构造性表达
功能性TS22基因产物将被测试其灭活能力
2-5A系统。Ts22基因产物失活的步骤(S)
将确定2-5A系统。进一步使用表达
野生型TS22基因或2-5A合成酶反义RNA应允许
2-5A系统在控制RNA降解中的作用评估
在细胞生长抑制期间,我们将确定这些载体的效果
干扰素或糖皮质激素诱导的生长抑制和减少
C-myc在Daudi细胞中的表达。
英文摘要
RNA turnover is central to the regulation of gene expression; however, the
mechanisms involved are not well understood. The temperature sensitive
mutant of vaccinia virus, ts22, provides a genetic tool for elucidating
mechanism(s) involved in RNA turnover. The ts22 gene regulates the
stability of RNA in vaccinia virus infected cells. ts22 virus has an
abortive late phenotype. At the non-permissive temperature, ts22 infection
proceeds normally in the early stages; however, at 8-10 h post infection,
RNA is degraded and virus infection aborted (independent of exogenous
interferon treatment). Our results indicate that the degradation of RNA is
due to the activation of 2-5A dependent RNase. 2-5A synthetase-RNase
pathway, initially discovered as one of the antiviral mechanisms of
interferon, has been implicated in controlling RNA turnover during cell
growth, hormone status and differentiation. The ability to modulate the 2-
5A pathway would be of value in assessing its role in RNA degradation. We
hypothesize that the functional ts22 gene product inactivates the 2-5A
system during productive infection. Inactivation of the 2-5A pathway by
expression of the functional ts22 gene product, independent of virus
infection, should help elucidate the role of 2-5A pathway in cellular RNA
turnover. We propose to study the modulation of 2-5A pathway by ts22 gene
product. This will be accomplished by determining the growth of ts22
vaccinia virus and rRNA cleavage (an indicator of activation of the 2-5A
system) at the non-permissive temperature, in cells in which the 2-5A
pathway has been rendered inoperative. Constitutive expression of the
functional ts22 gene product will be tested for its ability to inactivate
the 2-5A system. The step(s) at which the ts22 gene product inactivates
the 2-5A system will be determined. Further use of vectors expressing the
wild type ts22 gene or 2-5A synthetase antisense RNA should permit the
assessment of the role of the 2-5A system in controlling RNA degradation
during cell growth inhibition and we will determine effect of these vectors
on the interferon or glucocorticoid induced growth inhibition and reduction
in c-myc expression in Daudi cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevention of VZV Reactivation
-
批准号:8476910
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:8617880
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:8794483
-
项目类别:
-
资助金额:$33.97万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Prevention of VZV Reactivation
-
批准号:9208821
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2013
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10343676
-
项目类别:
-
资助金额:$43.82万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:9491548
-
项目类别:
-
资助金额:$45.02万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10542746
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Investigating the VZV-induced epigenetic modifications of vascular adventitial fibroblasts that contribute to persistent inflammation and VZV vasculopathy
-
批准号:10097966
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2009
-
负责人:RANDALL J. COHRS
-
依托单位:
Varicella Zoster Virus Latency in Human Ganglia
-
批准号:6746034
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2003
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6565246
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2001
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6410649
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2000
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6302840
-
项目类别:
-
资助金额:$26.91万
-
财政年份:1999
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6346297
-
项目类别:
-
资助金额:$24.29万
-
财政年份:1999
-
负责人:RANDALL J. COHRS
-
依托单位:
INTERACTION OF VZV GENES TRANSCRIBED DURING LATENCY IN HUMAN GANGLIA
-
批准号:6112506
-
项目类别:
-
资助金额:$26.91万
-
财政年份:1998
-
负责人:RANDALL J. COHRS
-
依托单位:
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
-
批准号:3145435
-
项目类别:
-
资助金额:$14.46万
-
财政年份:1990
-
负责人:RANDALL J. COHRS
-
依托单位:
CONTROL OF 2-5A PATHWAY BY TS MUTANT OF VACCINIA
-
批准号:3145434
-
项目类别:
-
资助金额:$13.5万
-
财政年份:1990
-
负责人:RANDALL J. COHRS
-
依托单位:
Varicella Zoster Virus Latency in Human Ganglia
-
批准号:7425976
-
项目类别:
-
资助金额:$38.38万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
ROLE OF VZV IE63 IN VZV LATENCY AND REACTIVATION
-
批准号:8377749
-
项目类别:
-
资助金额:$33.42万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
Varicella Zoster Virus Latency in Human Ganglia
-
批准号:7214717
-
项目类别:
-
资助金额:$35.24万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
ROLE OF VZV IE63 IN VZV LATENCY AND REACTIVATION
-
批准号:8230848
-
项目类别:
-
资助金额:$33.41万
-
财政年份:--
-
负责人:RANDALL J. COHRS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: